Emerald Advisers’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-642,226
| Closed | -$2.65M | – | 363 |
|
2020
Q3 | $2.65M | Sell |
642,226
-26,816
| -4% | -$110K | 0.11% | 122 |
|
2020
Q2 | $1.71M | Buy |
669,042
+37,595
| +6% | +$96.3K | 0.07% | 128 |
|
2020
Q1 | $1.83M | Buy |
631,447
+2,323
| +0.4% | +$6.71K | 0.11% | 117 |
|
2019
Q4 | $2.38M | Sell |
629,124
-9,970
| -2% | -$37.8K | 0.1% | 121 |
|
2019
Q3 | $3.27M | Sell |
639,094
-61,082
| -9% | -$312K | 0.15% | 114 |
|
2019
Q2 | $4.34M | Buy |
700,176
+73,929
| +12% | +$458K | 0.17% | 113 |
|
2019
Q1 | $4.45M | Sell |
626,247
-24,102
| -4% | -$171K | 0.18% | 116 |
|
2018
Q4 | $5.55M | Sell |
650,349
-12,195
| -2% | -$104K | 0.27% | 105 |
|
2018
Q3 | $13.3M | Buy |
662,544
+22,610
| +4% | +$453K | 0.49% | 93 |
|
2018
Q2 | $16.5M | Buy |
639,934
+13,821
| +2% | +$357K | 0.62% | 78 |
|
2018
Q1 | $15M | Buy |
626,113
+83,216
| +15% | +$1.99M | 0.6% | 71 |
|
2017
Q4 | $18.4M | Buy |
542,897
+14,830
| +3% | +$503K | 0.71% | 56 |
|
2017
Q3 | $11.2M | Sell |
528,067
-4,660
| -0.9% | -$98.7K | 0.45% | 87 |
|
2017
Q2 | $9.32M | Buy |
532,727
+14,042
| +3% | +$246K | 0.39% | 96 |
|
2017
Q1 | $9.08M | Buy |
518,685
+140
| +0% | +$2.45K | 0.37% | 99 |
|
2016
Q4 | $8.76M | Buy |
518,545
+14,071
| +3% | +$238K | 0.37% | 98 |
|
2016
Q3 | $8.28M | Sell |
504,474
-5,720
| -1% | -$93.9K | 0.37% | 101 |
|
2016
Q2 | $7.72M | Hold |
510,194
| – | – | 0.37% | 97 |
|
2016
Q1 | $7.38M | Buy |
510,194
+48,143
| +10% | +$696K | 0.36% | 97 |
|
2015
Q4 | $13.1M | Buy |
462,051
+110,530
| +31% | +$3.13M | 0.62% | 60 |
|
2015
Q3 | $5.88M | Buy |
351,521
+2,800
| +0.8% | +$46.9K | 0.31% | 111 |
|
2015
Q2 | $9.14M | Buy |
348,721
+26,090
| +8% | +$684K | 0.44% | 77 |
|
2015
Q1 | $5.65M | Buy |
322,631
+82,464
| +34% | +$1.44M | 0.28% | 118 |
|
2014
Q4 | $4.17M | Buy |
240,167
+79,704
| +50% | +$1.38M | 0.22% | 135 |
|
2014
Q3 | $2.99M | Buy |
160,463
+8,844
| +6% | +$165K | 0.18% | 164 |
|
2014
Q2 | $2.77M | Buy |
+151,619
| New | +$2.77M | 0.16% | 174 |
|